New Study Findings Published in Nature Show Circulating Tumor DNA (ctDNA) Can Predict and Detect Cancer Recurrence Earlier In Non-Small Cell Lung Cancer

– Highlights the use of Invitae’s personalized cancer monitoring (PCM) technology to correlate clinical outcomes with minimal residual disease (MRD) presence – – The analysis demonstrates the utility of ctDNA as a highly sensitive and specific biomarker for cancer recurrence – – Study…